HomeCompareKIKOY vs JNJ

KIKOY vs JNJ: Dividend Comparison 2026

KIKOY yields 1.94% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KIKOY wins by $56.34M in total portfolio value
10 years
KIKOY
KIKOY
● Live price
1.94%
Share price
$17.52
Annual div
$0.34
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.37M
Annual income
$51,292,269.88
Full KIKOY calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — KIKOY vs JNJ

📍 KIKOY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKIKOYJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KIKOY + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KIKOY pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KIKOY
Annual income on $10K today (after 15% tax)
$164.95/yr
After 10yr DRIP, annual income (after tax)
$43,598,429.40/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, KIKOY beats the other by $43,594,443.41/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KIKOY + JNJ for your $10,000?

KIKOY: 50%JNJ: 50%
100% JNJ50/50100% KIKOY
Portfolio after 10yr
$28.20M
Annual income
$25,648,479.64/yr
Blended yield
90.95%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

KIKOY
No analyst data
Altman Z
7.0
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KIKOY buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKIKOYJNJ
Forward yield1.94%2.13%
Annual dividend / share$0.34$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%28%
Portfolio after 10y$56.37M$30.3K
Annual income after 10y$51,292,269.88$4,689.40
Total dividends collected$55.96M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: KIKOY vs JNJ ($10,000, DRIP)

YearKIKOY PortfolioKIKOY Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,088$388.13$10,592$272.30+$496.00KIKOY
2$12,669$804.41$11,289$357.73+$1.4KKIKOY
3$15,273$1,717.91$12,123$472.89+$3.1KKIKOY
4$20,214$3,871.24$13,141$629.86+$7.1KKIKOY
5$31,205$9,576.52$14,408$846.81+$16.8KKIKOY
6$61,023$27,633.39$16,021$1,151.60+$45.0KKIKOY
7$166,300$101,005.74$18,122$1,588.22+$148.2KKIKOY
8$692,449$514,507.42$20,930$2,228.20+$671.5KKIKOY
9$4,745,272$4,004,352.10$24,792$3,191.91+$4.72MKIKOY
10$56,369,711$51,292,269.88$30,274$4,689.40+$56.34MKIKOY

KIKOY vs JNJ: Complete Analysis 2026

KIKOYStock

Kikkoman Corporation, through its subsidiaries, manufactures and sells food products in Japan, North America, and internationally. The company offers soy sauces, soy sauce soup bases, dipping and marinade sauces, handy seasoning mixes, and Del Monte seasonings; soy milk and Del Monte beverages; sweet sake for cooking; and wines. It also manufactures and sells canned fruits, canned corn, and tomato ketchup, as well as health foods; and purchases and sells oriental food products. In addition, the company produces and sells clinical diagnostic reagents, hygiene inspection agents, and processing enzymes, as well as chemical products, including hyaluronic acid; and offers real estate rental, logistics, and back-office support services. It serves home, and industrial and food service sectors. The company was formerly known as Kikkoman Shoyu Co., Ltd. and changed its name to Kikkoman Corporation in 1980. Kikkoman Corporation was founded in 1917 and is headquartered in Noda, Japan.

Full KIKOY Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this KIKOY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KIKOY vs SCHDKIKOY vs JEPIKIKOY vs OKIKOY vs KOKIKOY vs MAINKIKOY vs ABBVKIKOY vs MRKKIKOY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.